The distribution is narrowly covered by the issuer’s carry measure, but book erosion and leverage demand a larger margin of safety. Three explicit equity-value routes cluster near $7.50. We require stable capital and stronger income coverage before treating the high yield as adequate compensation.
Twelve-month equity-value scenarios; future dividends are separate.
| Case | Probability | Value |
|---|---|---|
| Bear | 30% | $5.50 |
| Base | 50% | $7.50 |
| Bull | 20% | $10.00 |
| Scenario | Probability | 12-month value | vs $8.44 | What has to happen | The arithmetic |
|---|---|---|---|---|---|
| Bear | 30% | $5.50 | −35% | Further spread widening and a weaker capital base; payout rebased. | Assumed $6.10 future tangible book × 0.90 = $5.49, rounded $5.50. |
| Base | 50% | $7.50 | −11% | Income moderates and book stabilizes; no full reversal of the quarter loss. | Current $7.13 book × 1.05 = $7.49; two income routes $7.43–$7.50; rounded $7.50. |
| Bull | 20% | $10.00 | +18% | MBS spreads recover, capital gains restore book, premium persists. | Assumed $8.70 future book × 1.15 = $10.005, rounded $10.00. |
| Computed weighted capital value: 30% × $5.50 + 50% × $7.50 + 20% × $10.00 = $7.40. Subjective probabilities; no guaranteed outcome. | |||||
| Signpost | Now (Q3 2026) | Green if | Red if | Next check |
|---|---|---|---|---|
| Tangible book | $7.13 | At least $7.13 | Below $6.50 | 2026-12-31 / next actual release |
| Economic return | −12.7% | At least 0% | Below -5% | 2026-12-31 / next actual release |
| Spread EPS / payout | $0.37 / $0.36 | At least $0.40 / payout ≤$0.36 | EPS below declared payout | 2026-12-31 / next actual release |
| At-risk leverage | 7.9× | At most 7.5× with stable carry | Above 8.5× | 2026-12-31 / next actual release |
| Unencumbered liquidity | $6.3B | At least $6.0B | Below $5.0B | 2026-12-31 / next actual release |
| Net spread | 1.86% | At least 2.00% | Below 1.60% | 2026-12-31 / next actual release |
| Price discipline | $8.44 reference | At most $6.00 plus stable fundamentals | Premium >20% while book falls | 2026-10-20 onward; review after new data |
Thresholds are analyst decision rules, not management promises. Verify the same metric definitions at the next actual disclosure.
AGNC is a mortgage portfolio financed with short-term borrowing. The investment question is whether income and changes in capital, taken together, compensate an owner for that leverage. The quarterly cash distribution remains attractive on its own, but the September loss in tangible book exceeded the dividend by a wide margin. A price chart that excludes dividends also understates the income received along the way. Both omissions matter: price alone is not total return, and dividend yield alone is not economic profit.
Our valuation reference is the FMP quote of $8.44, timestamped 2026-10-19T15:00:01-05:00. The timestamp is just after the regular-session close. It is a dated quote snapshot, not a verified after-hours earnings reaction. The SEC accepted the earnings filing at 15:03:07 CDT on October 19. We classify the release as after U.S. market close; its exact public release minute remains unconfirmed. The call is scheduled for October 20 at 07:30 CDT and had not occurred at this research cutoff.
| Date | Close |
|---|---|
| 2025-07-21 | $9.23 |
| 2025-08-18 | $9.58 |
| 2025-09-16 | $10.13 |
| 2025-10-14 | $10.01 |
| 2025-11-11 | $10.31 |
| 2025-12-10 | $10.38 |
| 2026-01-09 | $11.41 |
| 2026-02-09 | $11.34 |
| 2026-03-10 | $10.72 |
| 2026-04-08 | $10.32 |
| 2026-05-06 | $10.79 |
| 2026-06-04 | $10.29 |
| 2026-07-06 | $11.17 |
| 2026-08-03 | $10.64 |
| 2026-08-31 | $10.73 |
| 2026-09-29 | $9.45 |
| 2026-10-19 | $8.44 |
| Release | Next session | Price return |
|---|---|---|
| 2024-10-21 | 2024-10-22 | −3.56% |
| 2025-01-27 | 2025-01-28 | +0.82% |
| 2025-04-21 | 2025-04-22 | +3.55% |
| 2025-07-21 | 2025-07-22 | +1.52% |
| 2025-10-20 | 2025-10-21 | −0.50% |
| 2026-01-26 | 2026-01-27 | +3.14% |
| 2026-04-20 | 2026-04-21 | +1.30% |
| 2026-07-20 | 2026-07-21 | −1.28% |
| 2026-10-19 | Pending | Pending |
The provider market-cap and float records do not yet reflect the share total in the new release. FMP embeds 1,185.48 million shares; the issuer reports 1,261.8 million at quarter end. We therefore value each common share directly and use issuer shares when illustrating aggregate equity. No stale provider share denominator is allowed to inflate per-share value. The quoted 52-week range is $8.39–$12.19; that history describes trading, not a floor beneath the investment.
Gross interest income was $1,196 million, up 32.4% from $903 million a year earlier. Interest expense was $794 million, leaving $402 million of GAAP net interest income. That spread subtotal cannot stand in for the final result: losses on securities and offsetting hedges dominate the rest of the statement. After operating expense and preferred dividends, common shareholders absorbed a $1,402 million GAAP loss. Comprehensive common loss was $1,542 million after other comprehensive losses.
The headline non-GAAP spread and dollar roll measure was $0.37 a share, compared with $0.40 in June and $0.35 a year earlier. This measure removes market-value movements and adjusts other components to focus on portfolio carry. It is useful for understanding a recurring earnings engine, but it is not interchangeable with the GAAP loss or with the change in economic wealth. A mortgage portfolio can produce positive carry while its capital value falls faster than the income accrues.
| Quarter ended | Gross interest income | Interest expense |
|---|---|---|
| 2024-09-30 | 756.00 | 820.00 |
| 2024-12-31 | 856.00 | 741.00 |
| 2025-03-31 | 846.00 | 687.00 |
| 2025-06-30 | 830.00 | 668.00 |
| 2025-09-30 | 903.00 | 755.00 |
| 2025-12-31 | 944.00 | 738.00 |
| 2026-03-31 | 1,050.00 | 731.00 |
| 2026-06-30 | 1,014.00 | 709.00 |
| 2026-09-30 | 1,196.00 | 794.00 |
| Quarter ended | GAAP diluted EPS | Net spread and dollar roll EPS |
|---|---|---|
| 2024-09-30 | 0.39 | 0.43 |
| 2024-12-31 | 0.10 | 0.37 |
| 2025-03-31 | 0.02 | 0.44 |
| 2025-06-30 | −0.17 | 0.38 |
| 2025-09-30 | 0.72 | 0.35 |
| 2025-12-31 | 0.83 | 0.35 |
| 2026-03-31 | −0.17 | 0.42 |
| 2026-06-30 | 0.52 | 0.40 |
| 2026-09-30 | −1.17 | 0.37 |
| Metric | Q3 2026 | Q2 2026 | Q3 2025 |
|---|---|---|---|
| Gross interest income $M | 1,196.00 | 1,014.00 | 903.00 |
| Net interest income $M | 402.00 | 305.00 | 148.00 |
| Common net income $M | −1,402.00 | 610.00 | 764.00 |
| Comprehensive common income $M | −1,542.00 | 603.00 | 825.00 |
| GAAP EPS $ | −1.17 | 0.52 | 0.72 |
| Spread EPS $ | 0.37 | 0.40 | 0.35 |
| Dividend $ | 0.36 | 0.36 | 0.36 |
| Tangible book $ | 7.13 | 8.58 | 8.28 |
FMP’s earnings record compares actual EPS of $0.37 with an estimate of $0.3724. That actual matches the issuer’s non-GAAP measure, so it must not be described as a GAAP earnings miss. Its $1,196 million actual revenue field matches gross interest income, compared with $1,056.86 million estimated. The apparent top-line beat does not offset a capital loss. Consensus definitions can differ across providers; the release’s labeled financial statements control our analysis.
AGNC reports one operating segment. Assigning separate segment revenue or profit to Agency mortgages, Treasury hedges and TBA positions would invent a disclosure that management has not provided. We instead map the actual asset classes and their economic jobs. Agency mortgage securities supply most of the exposure, Treasury and swap positions manage interest-rate risk, and repurchase agreements provide financing. Credit-risk-transfer and other non-Agency positions are much smaller, but their credit risks are different from those of guaranteed Agency pools.
The release places total investments, including forward positions and other mortgage-credit assets, at $94.4 billion. Thirty-year fixed-rate Agency MBS and TBAs comprise 94% of that portfolio. Agency support reduces mortgage credit exposure; it does not guarantee the common stock, its dividend, its market price or its financing terms. Mortgage spreads can widen relative to the benchmark curve even when principal and interest on the underlying bonds remain protected. That basis risk is central to the current loss.
| Quarter ended | Fixed Agency MBS | Other Agency MBS | Net TBA | Credit risk transfer |
|---|---|---|---|---|
| 2024-09-30 | 66,668.00 | 1,376.00 | 4,068.00 | 620.00 |
| 2024-12-31 | 64,049.00 | 1,415.00 | 6,861.00 | 633.00 |
| 2025-03-31 | 68,468.00 | 1,990.00 | 7,473.00 | 640.00 |
| 2025-06-30 | 71,104.00 | 2,219.00 | 8,263.00 | 613.00 |
| 2025-09-30 | 73,283.00 | 3,003.00 | 13,841.00 | 609.00 |
| 2025-12-31 | 77,483.00 | 3,605.00 | 12,988.00 | 606.00 |
| 2026-03-31 | 80,466.00 | 3,981.00 | 9,548.00 | 593.00 |
| 2026-06-30 | 82,334.00 | 4,450.00 | 9,728.00 | 573.00 |
| 2026-09-30 | 86,874.00 | 4,520.00 | 2,368.00 | 515.00 |
| Quarter ended | Economic asset yield % | Economic funding cost % | Net interest spread % |
|---|---|---|---|
| 2024-09-30 | 4.73 | 2.52 | 2.21 |
| 2024-12-31 | 4.80 | 2.89 | 1.91 |
| 2025-03-31 | 4.87 | 2.75 | 2.12 |
| 2025-06-30 | 4.87 | 2.86 | 2.01 |
| 2025-09-30 | 4.95 | 3.17 | 1.78 |
| 2025-12-31 | 4.91 | 3.10 | 1.81 |
| 2026-03-31 | 4.98 | 2.92 | 2.06 |
| 2026-06-30 | 4.89 | 2.89 | 2.00 |
| 2026-09-30 | 4.95 | 3.09 | 1.86 |
The economic asset yield increased to 4.95%, but total economic funding costs rose to 3.09%, leaving a 1.86% net spread against 2.00% in June. A higher asset yield does not automatically improve earnings if funding and hedge costs move faster. The TBA portfolio also declined sharply during the quarter. A change in portfolio form can alter financing economics and reported gains without creating an independent business segment.
| Quarter ended | Actual CPR % |
|---|---|
| 2024-09-30 | 7.30 |
| 2024-12-31 | 9.60 |
| 2025-03-31 | 7.00 |
| 2025-06-30 | 8.70 |
| 2025-09-30 | 8.30 |
| 2025-12-31 | 9.70 |
| 2026-03-31 | 13.20 |
| 2026-06-30 | 13.00 |
| 2026-09-30 | 8.20 |
Actual quarterly prepayments slowed to an 8.2% annualized CPR, while projected life CPR fell to 6.7%. Slower refinancing reduces premium amortization in the current accounting estimate, but can also extend asset duration when yields rise. We therefore do not label slower prepayments simply good or bad. Their effect depends on purchase premium, hedge positioning and the path of market rates. A forecast revision is not cash received from borrowers.
| Step | $M |
|---|---|
| Net interest | 402 |
| Other net loss | −1731 |
| Operating expense | −28 |
| Preferred dividends | −45 |
| Common net loss | −1402 |
The largest mark was a $5,015 million unrealized loss on investment securities recognized through earnings. The $3,301 million gain on derivatives and other investments partly offset that damage; it did not erase it. Realized securities losses were another $17 million. Describing the loss as merely noncash would miss the practical issue: collateral is marked to market, financing capacity depends on capital, and loss absorption matters even before an asset is sold.
| Measure | $M |
|---|---|
| GAAP comprehensive common loss | −1542 |
| Non-GAAP spread and dollar roll | 444 |
| Reconciliation from comprehensive common income | Q3 2026 $M |
|---|---|
| Comprehensive income (loss) available (attributable) to common stockholders | −1,542.0 |
| Realized (gain) loss on sale of investment securities, net | 17.0 |
| Unrealized (gain) loss on investment securities measured at fair value through net income, net | 5,015.0 |
| (Gain) loss on derivative instruments and other securities, net | −3,301.0 |
| Unrealized (gain) loss on available-for-sale securities measured at fair value through other comprehensive income, net | 140.0 |
| Estimated ”catch up” premium amortization cost (benefit) due to change in CPR forecast 3 | −66.0 |
| TBA dollar roll income 4,5 | 28.0 |
| Interest rate swap periodic income, net 4,6 | 153.0 |
| Other interest income (expense), net 4,7 | 0.0 |
| Net spread and dollar roll income available to common stockholders | 444.0 |
The carry measure removes the $66 million catch-up amortization benefit caused by the lower prepayment forecast, then includes periodic swap income and dollar rolls under the issuer’s definition. That exclusion is appropriate for separating an estimate change from ongoing carry. It does not make the remaining measure a complete shareholder return. Supplemental Treasury and option hedge effects are not all represented in the headline spread measure. Investors should track the actual reconciliation, not assume that every excluded component is a one-time item.
| Quarter ended | Weighted average common shares, M |
|---|---|
| 2024-09-30 | 807.20 |
| 2024-12-31 | 882.80 |
| 2025-03-31 | 918.30 |
| 2025-06-30 | 1,017.30 |
| 2025-09-30 | 1,053.00 |
| 2025-12-31 | 1,089.30 |
| 2026-03-31 | 1,122.60 |
| 2026-06-30 | 1,157.60 |
| 2026-09-30 | 1,200.50 |
Common shares outstanding rose from 1,164.2 million to 1,261.8 million during the quarter, a computed 8.38% increase. The ATM raised $992 million net on 97.6 million shares, or about $10.16 per new share. Issuing above contemporaneous tangible book can support existing owners’ per-share capital, unlike issuance below book. Yet accretive financing does not prove the investment portfolio generated a positive return; book still fell after the capital raise.
The scorecard keeps the same nine questions used for operating companies while respecting a mortgage REIT’s accounting. An industrial accrual ratio, inventory turnover calculation or Altman-style manufacturing score would give spurious precision here. We mark those inputs as not applicable and explain the replacement question. For AGNC, the useful questions are whether book is preserved, whether liquidity remains available, whether carry covers the distribution and whether funding or hedge costs are changing faster than asset yields.
Three-year operating cash flows were negative $118 million, positive $86 million and positive $653 million in 2023, 2024 and 2025. These amounts should not be compared mechanically with the common dividend to declare the business self-funding or insolvent. Purchases, repayments, hedges and repo flows run through other cash-flow classifications. The audited statement is retained in full so that the categories remain visible. Cash dividends in that statement include all share classes; a provider field calling them all common dividends is not accepted.
| Year | OCF $M | All-class dividends $M | SBC $M |
|---|---|---|---|
| 2023 | −118 | 1005 | 11 |
| 2024 | 86 | 1241 | 18 |
| 2025 | 653 | 1601 | 26 |
There is no separately disclosed capital-expenditure line in the collected annual statement, and the provider maps capex to zero. That is a reporting classification, not proof that all operating cash is available for distributions. The real capital requirement is equity supporting a marked and leveraged investment book. Likewise, modest staff costs do not make the portfolio low risk. The company had 54 full-time employees at year-end 2025, after 53 in each of the two prior year-end reports; market exposure is not measured by headcount.
Unencumbered cash and Agency MBS of $6.3 billion provide an important liquidity buffer, reported as 57% of tangible equity. That amount includes securities, not just bank cash. Balance-sheet cash and equivalents are $468 million, with another $1,765 million restricted. Calling the entire liquidity figure cash would overstate immediately free funds; ignoring the unpledged Agency collateral would understate the capacity available to meet margin requirements. We preserve all three concepts rather than collapsing them into one headline.
| Quarter ended | Tangible book per common share |
|---|---|
| 2024-09-30 | 8.82 |
| 2024-12-31 | 8.41 |
| 2025-03-31 | 8.25 |
| 2025-06-30 | 7.81 |
| 2025-09-30 | 8.28 |
| 2025-12-31 | 8.88 |
| 2026-03-31 | 8.38 |
| 2026-06-30 | 8.58 |
| 2026-09-30 | 7.13 |
| Quarter ended | At-risk leverage, times |
|---|---|
| 2024-09-30 | 7.20 |
| 2024-12-31 | 7.20 |
| 2025-03-31 | 7.50 |
| 2025-06-30 | 7.60 |
| 2025-09-30 | 7.60 |
| 2025-12-31 | 7.20 |
| 2026-03-31 | 7.40 |
| 2026-06-30 | 7.40 |
| 2026-09-30 | 7.90 |
At-risk leverage increased to 7.9 times from 7.4 times. The issuer’s denominator and funding definition matter: its investment-securities repo differs from total balance-sheet repo because Treasury financing supports a related hedge position. Total repo was $96,719 million, while investment-securities repo was approximately $85.7 billion. We do not subtract every dollar of repo from the quoted stock value as if AGNC were a factory with idle cash. The financed securities and associated hedges must be analyzed together.
| Capital and funding item | Q3 2026 | Interpretation |
|---|---|---|
| Unencumbered cash + Agency MBS | $6.3B | Liquidity buffer; includes securities |
| Cash / restricted cash | $468M / $1,765M | Different availability |
| Investment-securities repo | $85.7B | Excludes Treasury repo |
| Repo maturity | 10 days weighted average | Frequent refinancing and collateral management |
| Preferred liquidation preference | $2,033M | Senior capital ahead of common |
| Goodwill | $526M | Excluded from tangible book |
| Issuer common shares | 1,261.8M | Use for quarter-end share arithmetic |
| At-risk leverage | 7.9× | Issuer-defined funding / tangible equity |
A simple unhedged illustration shows why the margin of safety matters: assets equal to roughly equity plus 7.9 times funding would make a one-percent asset-value decline about an 8.9-percent equity hit before hedges, convexity, portfolio changes and financing effects. This is a teaching sensitivity, not the company’s modeled shock table. Actual hedge protection must be read on its own terms. A high hedge notional ratio does not eliminate mortgage-spread risk or guarantee protection against every rate path.
We assign SELL, conviction 3/5 and High uncertainty, with a rounded $7.50 central fair value and a $5.50–$10.00 scenario range. The $8.44 reference sits 18.4% above current tangible book. Our base implies 11.1% capital downside from the reference quote. A distribution can partly compensate for a declining share price, so the call is based on risk-adjusted total-return prospects rather than on capital downside alone. The model does not claim a dividend reduction has been announced.
$7.13 reported tangible book × 1.05 analyst premium = $7.4865. A modest premium recognizes internal management and capital access; it does not restore the lost book value.
$1.35 assumed annual spread EPS × 5.5 assumed multiple = $7.425. The input is below four times the current quarter and is not guidance. The low multiple recognizes recurring capital volatility.
$1.20 assumed sustainable annual distribution ÷ 16% required equity return = $7.50. This flat-distribution perpetuity is a stress-normalization cross-check, not a promised payout or a five-year cash-flow forecast.
These routes are related, not independent votes that manufacture confidence. Carry, dividends and book are generated by the same leveraged portfolio. The cross-check is useful because it makes our required return and payout assumptions explicit. A conventional enterprise-value discounted cash-flow model would obscure the economics by treating financing as an external capital-structure choice rather than part of the product. The dividend route is a direct equity model; no debt subtraction or terminal growth plug is hidden in it.
| Future book | 0.90× | 1.05× | 1.15× |
|---|---|---|---|
| $6.10 | $5.49 | $6.41 | $7.01 |
| $7.13 | $6.42 | $7.49 | $8.20 |
| $8.70 | $7.83 | $9.13 | $10.00 |
The market-implied test works in reverse. At a 16% required return, today’s price needs roughly $1.3504 of sustainable annual equity cash income with no growth. That is below the indicated $1.44 dividend, which explains the appeal of the shares, but leaves little tolerance for capital leakage or a lower sustainable payout. Alternatively, a price equal to current book would require 18.4% book recovery to reach the quote without a premium. Those are economic hurdles, not forecasts.
Our base value plus the assumed $1.20 distribution produces approximately 3.1% one-year total return from the reference quote. If the current $1.44 annualized payout persists instead, that illustrative return is 5.9%. Neither reaches the assumed 16% required return. The probability-weighted capital value is $7.40. We would require roughly a 20% discount to our base, or $6.00, plus stable book and funding evidence before considering a BUY. Price alone cannot repair an impaired thesis.
FMP’s collected rating distribution is 11 Buy, 21 Hold and 3 Sell, with a Hold consensus. Its target snapshot centers on $11, spans $10–$12 and implies 30.3% capital appreciation from the reference quote. Our SELL and $7.50 base are more cautious on both rating and valuation. The difference is explained by the book anchor and our return requirement, not by asserting that a consensus is automatically wrong. Targets may retain older portfolio assumptions until analysts digest the new print.
| Rating | Count |
|---|---|
| Buy | 11 |
| Hold | 21 |
| Sell | 3 |
| Comparison | Wall Street snapshot | Charged Alpha |
|---|---|---|
| Rating | Hold | SELL · conviction 3/5 |
| Central value | $11 target | $7.50 fair value |
| Range | $10–$12 | $5.50–$10.00 analyst scenarios |
| vs $8.44 | +30.3% | −11.1% |
| Freshness | No verified post-release revision yet | Q3 release explicitly incorporated |
The latest collected target-news record is dated October 9 and reports Piper Sandler reducing its target from $12 to $10 while maintaining Overweight. That is a provider-carried report, not an original broker research note we independently possess. July and April target records are still older. We therefore label the target table as pre-print context rather than fresh endorsement of September’s capital result. Ratings counts also need care: a database can aggregate records differently from a current analyst roster.
| Provider news date | Firm | Target | Freshness |
|---|---|---|---|
| 2026-10-09 | Piper Sandler | $10.00 | Before current release |
| 2026-07-02 | Piper Sandler | $12.00 | Before current release |
| 2026-04-24 | RBC Capital | $12.00 | Before current release |
| 2026-04-24 | UBS | $11.00 | Before current release |
| 2026-01-29 | RBC Capital | $13.00 | Before current release |
| Year | EPS average | EPS analysts |
|---|---|---|
| 2026 | 1.5639 | 8 |
| 2027 | 1.4541 | 9 |
| 2028 | 1.4571 | 1 |
Management supplies a qualitative constructive outlook for Agency mortgages, not a numerical EPS or tangible-book target in this release. We cannot honestly draw a management-versus-consensus forecast line that does not exist. The farthest-year provider estimate has only one EPS contributor; its precision should not be mistaken for broad agreement. The next meaningful update is the company call and subsequent source-dated analyst revisions.
Management argues that wider mortgage spreads improve prospective returns once Treasury volatility subsides, while high rates reduce refinancing incentives and mortgage supply. That case is economically coherent. It also carries a timing condition: the portfolio must retain enough liquidity and equity to benefit from normalization. Attractive new-asset yields do not reverse losses on the existing book immediately. We separate management’s opportunity claim from our evidence requirement that capital and carry stabilize together.
| Decision or claim | Evidence | Assessment / next test |
|---|---|---|
| Capital issuance | $992M net ATM proceeds on 97.6M shares | Positive above book; monitor per-share outcome |
| Capital preservation | Book $8.58 → $7.13; economic return -12.7% | Failed this quarter; require nonnegative next economic return |
| Income coverage | $0.37 spread EPS / $0.36 dividend | Narrow cushion; not comprehensive return |
| Liquidity | $6.3B unencumbered cash and Agency MBS | Useful buffer; preserve issuer definition |
| Risk positioning | 7.9× ending leverage versus 7.4× | More sensitive capital base; track funding terms |
| Outlook | Constructive Agency MBS view | Conditional, no numerical EPS promise |
| Cost discipline | $28M quarterly operating expense | Costs modest compared with market losses |
The annual report identifies an internally managed business, with Ernst & Young as auditor and effective internal controls reported for 2025. Neither fact insulates investors from market losses. The company’s common stock and preferred depositary securities are different claims; historical delisting notices reviewed in eligibility applied to retired preferred series rather than the continuing AGNC common. The current common-security review passed. Past clerical filing amendments were read and resolved individually rather than treated as permanent exclusions.
There is no prior Charged Alpha AGNC quarter in the canonical completed records to grade against. This packet starts a dated scorecard rather than inventing a track record. The follow-up should measure the same book, carry, funding and liquidity definitions. Management can be right about the long-run attractiveness of Agency mortgages while common shareholders still receive inadequate compensation at today’s price.
| Rank | Risk | Likelihood | Impact | Observable test |
|---|---|---|---|---|
| 1 | Mortgage spreads remain wide | High | High | Next book and economic-return disclosure |
| 2 | Repo funding / collateral pressure | Medium | High | Liquidity, maturities and financing counterparties |
| 3 | Carry and dividend reset | Medium | High | Spread EPS versus quarterly payout |
| 4 | Hedge basis / convexity mismatch | High | High | Book response across rate paths |
| 5 | Premium to book compresses | Medium | High | Price/book after source-dated results |
| 6 | Equity issuance below favorable economics | Medium | Medium | Net issue price versus contemporaneous book |
| 7 | REIT tax or regulatory constraints | Low | High | Current filings and compliance disclosures |
The bull case deserves full weight: Agency mortgage credit quality is strong, wider spreads improve prospective asset returns, and an eventual decline in volatility can produce book recovery alongside income. The company has scale, internal management and access to capital. If book returns toward the bull assumption and investors continue to reward the franchise with a premium, the scenario value reaches $10 before dividends. A short-term capital mark can reverse; treating every unrealized loss as permanent would be just as simplistic as ignoring it.
The bear case is that higher prospective yields arrive because risk has risen, not because a free return appeared. Short funding maturities and leveraged collateral can force repositioning before a recovery. Dividend coverage from a narrow non-GAAP measure may weaken as favorable hedge income rolls off. A premium stock price can fall even if book merely stops declining. Our probability weighting gives the bear greater weight than the bull because the current evidence shows capital erosion and limited carry headroom, while recovery remains conditional.
We land between those narratives on operations but below the quote on valuation. This is not a forecast that AGNC cannot survive or that every income investor must sell immediately. It is a research rating on prospective compensation for risk at the stated price. Investor tax circumstances, cash needs and portfolio exposure are outside this model. The falsifiable test is whether the next source disclosures support stable capital, adequate carry and resilient financing rather than merely repeating the yield headline.
| Date / window | Event | What would matter |
|---|---|---|
| 2026-10-20 07:30 CDT | Scheduled earnings call | Updated book, leverage and dividend discussion; release already occurred |
| 2026-11-16 review checkpoint | Q3 filing follow-up | Read filed 10-Q when available; date here is our review checkpoint |
| 2026-12-31 | Quarter-end measurement | Book, spread, leverage and capital allocation |
| 2027-01-31 review checkpoint | Next result-cycle review | Confirm actual release date; do not assume schedule |
| Monthly following declarations | Distribution decisions | Actual Board declarations, not annualized promises |
A catalyst is useful only if it can change the evidence. The call can clarify portfolio positioning and the latest book estimate, but a confident tone alone will not change the rating. A newly filed quarterly report may add collateral, counterparty or sensitivity details absent from the furnished release. We will update those disclosures when actual documents arrive rather than backfilling estimates as reported facts. Dates identified as review checkpoints are our calendar, not company-announced reporting commitments.
The strongest upgrade combination would be stable or improving book, carry comfortably above the distribution and sufficient liquidity at a more attractive entry valuation. A stock-price decline without those conditions can simply reflect deteriorating economics. Conversely, a book recovery and lower funding risk could justify revisiting the premium even if the shares have risen. This framework keeps the decision attached to capital and return, rather than anchoring to the purchase price or a historical high.
| Quarter | Gross interest $M | Net interest $M | Common GAAP $M | Spread EPS $ | Book $ | Dividend $ | Leverage |
|---|---|---|---|---|---|---|---|
| 2024-09-30 | 756.00 | −64.00 | 313.00 | 0.43 | 8.82 | 0.36 | 7.20 |
| 2024-12-31 | 856.00 | 115.00 | 86.00 | 0.37 | 8.41 | 0.36 | 7.20 |
| 2025-03-31 | 846.00 | 159.00 | 15.00 | 0.44 | 8.25 | 0.36 | 7.50 |
| 2025-06-30 | 830.00 | 162.00 | −178.00 | 0.38 | 7.81 | 0.36 | 7.60 |
| 2025-09-30 | 903.00 | 148.00 | 764.00 | 0.35 | 8.28 | 0.36 | 7.60 |
| 2025-12-31 | 944.00 | 206.00 | 908.00 | 0.35 | 8.88 | 0.36 | 7.20 |
| 2026-03-31 | 1,050.00 | 319.00 | −192.00 | 0.42 | 8.38 | 0.36 | 7.40 |
| 2026-06-30 | 1,014.00 | 305.00 | 610.00 | 0.40 | 8.58 | 0.36 | 7.40 |
| 2026-09-30 | 1,196.00 | 402.00 | −1,402.00 | 0.37 | 7.13 | 0.36 | 7.90 |
| Fiscal year | OCF $M | Capex mapped $M | SBC $M | All-class cash dividends $M | Common buybacks $M | Employees |
|---|---|---|---|---|---|---|
| 2025 | 653.0 | 0 | 26.0 | 1601.0 | 0 | 54 |
| 2024 | 86.0 | 0 | 18.0 | 1241.0 | 0 | 53 |
| 2023 | −118.0 | 0 | 11.0 | 1005.0 | 0 | 53 |
| Annual cash-flow amounts from FY2025 10-K comparative statements; employees from each corresponding annual report. No capex valuation inference. | ||||||
The source hierarchy is issuer filings first, then labeled market-provider context, then computed analytical assumptions. Current and comparative quarterly financial statements come from the October 2026 and October 2025 earnings exhibits, spanning nine quarters without treating year-to-date totals as quarters. All below-the-line and reconciliation rows are retained in the dataset, including items not plotted on the page. Annual cash flows come from audited comparative statements. The current quarterly release is unaudited, and the call had not yet happened at authoring.
Tangible book subtracts goodwill and senior preferred capital from the capital attributable to common shares under the issuer’s definition. Economic return combines the change in tangible book with declared dividends, divided by beginning tangible book; it is not the stock’s market total return. Net spread and dollar roll income is the issuer’s non-GAAP carry measure. TBA means to-be-announced forward mortgage securities. CPR is an annualized prepayment rate. Repo means collateralized repurchase financing. These definitions prevent the same word, such as income or cash, from silently changing meaning between charts.
All changes, ratios, scenario weights and valuation products are computed from the retained dataset. The $7.50 central estimate is a rounded editorial conclusion, not an observable market fact. Scenario probabilities are subjective and sum to one hundred percent. The sensitivity grid changes book and valuation multiple independently for illustration, though those variables may be correlated in stress. Estimates use nominal U.S. dollars. There is no foreign-exchange conversion, ADR ratio, industrial enterprise-value multiple or assumed unreported business segment in the model.